A systematic review and economic model of the effectiveness and ...

hyperactive boys: comparative and combined
effects. J Consult Clin Psychol 1984;52:739–49.
284. Hinshaw SP, Buhrmester D, Heller T. Anger
control in response to verbal provocation: effects
of stimulant medication for boys with ADHD.
J Abnorm Child Psychol 1989;17:393–407.
285. Hinshaw SP, Henker B, Whalen CK, Erhardt D,
Dunnington REJ. Aggressive, prosocial, and
nonsocial behaviour in hyperactive boys: dose
effects of methylphenidate in naturalistic settings.
J Consult Clin Psychol 1989;57:636–43.
286. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM,
Pollack S. Clinical efficacy of methylphenidate in
conduct disorder with and without attention deficit
hyperactivity disorder. Arch Gen Psychiatry
1997;54:1073–80.
287. Long N, Rickert VI, Ashcraft EW. Bibliotherapy as
an adjunct to stimulant medication in the
treatment of attention-deficit hyperactivity
disorder. J Pediatr Health Care 1993;7:82–8.
288. Lufi D, Parish-Plass J, Gai E. The effect of
methylphenidate on the cognitive and personality
functioning of ADHD children. Isr J Psychiatry
Relat Sci 1997;34:200–9.
289. Matochik JA, Liebenauer LL, King C, Szymanski
HV, Cohen RM, Zametkin AJ. Cerebral glucose
metabolism in adults with attention deficit
hyperactivity disorder after chronic stimulant
treatment. Am J Psychiatry 1994;151:658–64.
290. McBride MC. An individual double-blind
crossover trial for assessing methylphenidate
response in children with attention deficit
disorder. J Pediatr 1988;113:137–45.
291. Pelham WE, Hoza B, Kipp HL, Gnagy EM,
Trane ST. Effects of methylphenidate and
expectancy of ADHD children’s performance, selfevaluations,
persistence, and attributions on a
cognitive task. Exp Clin Psychopharmacol
1997;5:3–13.
292. Quinn PO, Rapoport JL. One-year follow-up of
hyperactive boys treated with imipramine or
methylphenidate. Am J Psychiatry 1975;132:241–5.
293. Rapport MD, Carlson GA, Kelly KL, Pataki C.
Methylphenidate and desipramine in hospitalized
children: I. Separate and combined effects on
cognitive function. J Am Acad Child Adolesc
Psychiatry 1993;32:333–42.
294. Solanto MV, Wender EH, Bartell SS. Effects of
methylphenidate and behavioral contingencies on
sustained attention in attention-deficit
hyperactivity disorder: a test of the reward
dysfunction hypothesis. J Child Adolesc
Psychoparmacol 1997;7:123–36.
295. Spencer T, Wilens T, Biedermanm J, Faraone SV,
Ablon JS, Lapey K. A double-blind, crossover
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Health Technology Assessment 2006; Vol. 10: No. 23
comparison of methylphenidate and placebo in
adults with childhood-onset attention-deficit
hyperactivity disorder. Arch Gen Psychiatry
1995;52:434–43.
296. Wender PH, Reimherr FW, Wood D, Ward M.
A controlled study of methylphenidate in the
treatment of attention deficit disorder, residual
type, in adults. Am J Psychiatry 1985;142:547–52.
297. Winsberg BG, Press M, Bialer I, Kupietz S.
Dextroamphetamine and methylphenidate in the
treatment of hyperactive-aggressive children.
Pediatrics 1974;53:236–41.
298. Zametkin A, Rapoport JL, Murphy DL,
Linnoila M, Ismond D. Treatment of hyperactive
children with monoamine oxidase inhibitors: I,
clinical efficacy. Arch Gen Psychiatry 1985;42:962–6.
299. Arnold LE, Pinkham SM, Votolato N. Does zinc
moderate essential fatty acid and amphetamine
treatment of attention-deficit/hyperactivity disorder?
J Child Adolesc Psychopharmacol 2000;10:111–17.
300. Efron D, Jarman FC, Barker MJ. Methylphenidate
vs dexamphetamine in children with attention
deficit hyperactivity disorder: a double-blind crossover
trial. J Paediatr Child Health 1997;33:A21.
301. Efron D, Jarman FC, Barker MJ. Child and parent
perceptions of stimulant medication treatment in
attention deficit hyperactivity disorder. J Paediatr
Child Health 1998;34:288–92.
302. Castellanos FX, Elia J, Kruesi MJ, Marsh WL,
Gulotta CS, Potter WZ, et al. Cerebrospinal fluid
homovanillic acid predicts behavioral response to
stimulants in 45 boys with attention
deficit/hyperactivity disorder.
Neuropsychopharmacology 1996;14:125–37.
303. Handen BL, Feldman HM, Lurier A, Murray PJH.
Efficacy of methylphenidate among preschool
children with developmental disabilities and
ADHD. In Hertzig ME, Farber E, editors. Annual
progress in child psychiatry and child development:
2000–2001. New York: Brunner Routledge; 2003.
pp. 247–62.
304. Klorman R, Coons HW, Borgstedt AD. Effects of
methylphenidate on adolescents with a childhood
history of attention deficit disorder: I. Clinical
findings (Erratum). J Am Acad Child Adolesc
Psychiatry 1987;26:820.
305. Dittmann R, Fouche DS, Kratochvil C,
Heiligenstein J, Spencer T, Biederman J.
Atomoxetine and methylphenidate treatment in
children with ADHD: a prospective, randomized,
open-label trial. Eur Neuropsychopharmacol 2001;11
(Suppl 3):S318.
306. Findling RL, Short EJ, Manos MJ. Short-term
cardiovascular effects of methylphenidate and
Adderall. J Am Acad Child Adolesc Psychiatry
2001;40:525–9.
145